General Study confirms continued effectiveness of antibodies and vaccines used to prevent RSV infectionsBy Healthcare Propulsion StaffSeptember 16, 20260 An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants associated…
General Stage 1 findings support continued pivotal phase evaluation of gotistobartBy Healthcare Propulsion StaffSeptember 15, 20260 Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed following PD-(L)1 inhibitor therapy experienced a median overall…
